[1]JournalofMedicinalChemistry,1988,vol.31,p.254-260
[1]JournalofMedicinalChemistry,1988,vol.31,p.254-260
[1]JournalofMedicinalChemistry,1988,vol.31,p.254-260
Title: Screening of a chemical library reveals novel PXR-activating pharmacologic compounds.
Journal: Toxicology letters 20150105
Title: Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer.
Journal: PLoS computational biology 20120201
Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Journal: PLoS computational biology 20111201
Title: Evaluation of a 25-year-program for the control of schistosomiasis mansoni in an endemic area in Brazil.
Journal: PLoS neglected tropical diseases 20110301
Title: Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding.
Journal: PloS one 20110101
Title: A predictive ligand-based Bayesian model for human drug-induced liver injury.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20101201
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening.
Journal: PLoS neglected tropical diseases 20101001
Title: Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay.
Journal: Antimicrobial agents and chemotherapy 20100901
Title: Identification of novel p53 pathway activating small-molecule compounds reveals unexpected similarities with known therapeutic agents.
Journal: PloS one 20100101
Title: Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni.
Journal: PLoS neglected tropical diseases 20090801
Title: Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening.
Journal: PLoS neglected tropical diseases 20090701
Title: Mefloquine--an aminoalcohol with promising antischistosomal properties in mice.
Journal: PLoS neglected tropical diseases 20090101
Title: The NIH-NIAID schistosomiasis resource center.
Journal: PLoS neglected tropical diseases 20080701
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.
Journal: Chemical research in toxicology 20050601
Title: Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.
Journal: The Journal of pharmacology and experimental therapeutics 19760601
Title: Mamta D Naidu, et al. Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding. PLoS One. 2011;6(9):e23679.
Title: Pica Mattoccia L, et al. Effect of hycanthone administered in vivo upon the incorporation of radioactive precursors into macromolecules of Schistosoma mansoni. Mol Biochem Parasitol. 1983 Jun;8(2):99-107.
Title: Hahon N, et al. Action of antischistosomal drugs, hycanthone and its analog 1A-4 N-oxide, on viral interferon induction. J Toxicol Environ Health. 1980 Jul;6(4):705-12.
